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ABSTRACT  
Diabetes mellitus is globally one of the threatening disease which is creating 
a havoc worldwide. The oral hypoglycaemic drugs in many patients do not 
produce desired effects and those who respond, gradually lead to the 
therapeutic failure in the later stages of the disease. So, in the present 
situation to overcome this problem it is highly needed to break through an 
alternative therapy. In view of the above fact the present study was 
undertaken, whereby the drug taken was Amrita-Shilajit yoga, as a 
combination drug having Rasayana properties and the subjective parameters 
taken for assessing was Agni and Ojas, along with objective, laboratory 
parameters like Fasting Blood sugar and Post prandial sugar for evaluating 
the benefits of the drug in Diabetes Mellitus. Three groups were taken (n=30, 
10 for each group). Group A, receiving Amrita Shilajatu yoga, Group B 
receiving modern drug and Group C receiving both the drug. In case of group 
A mean reduction of all the clinical parameters are more than that of Group 
B. Statistically significant improvement was observed in objective and 
subjective parameters in all 3 groups after completion of the course of 
treatment. The present study not only corrects the metabolic error by 
maintaining the Agni in equilibrium but also overcomes its various 
complications by stabilizing the status of Ojas in NIDDM patients.  
INTRODUCTION 
 Incidence of Diabetes mellitus is increasing 
day by day and present day civilisation use of diet rich 
in carbohydrates and fat with lack of physical labour 
and excessive mental stress and strain is often 
supposed to be responsible for it. Although the exact 
aetiopathogenesis of this disease is yet to be defined, 
the major morbidity swings around the problems 
related to insulin resistance. The altered immune 
function is also considered to be contributory factor. 
Regarding management the challenge for the medical 
profession has also increased not because of, we are 
unable to control the anomalies of carbohydrate 
metabolism, the chief derangement of the disease with 
the available drugs, but because of the complications 
which are difficult enough to be controlled inspite of 
full control of sugar metabolism. 
 Although the number of patients of Insulin 
Dependent Diabetes is very small but their prognosis 
is bad because of a very limited choice of treatment. In 
case of non-Insulin dependent Diabetics the 
introduction of oral hypoglycaemic drugs in modern 
medicine few decades back brought a big hope for 
diabetics but the experiences of past few decades with 
the use of this category of drugs have revealed many 
limitations such as drug resistance and major adverse 
effects. The oral hypoglycaemic drugs in many 
patients do not produce desired effects and those who 
respond, gradually lead to the therapeutic failure in 
the later stages of the disease. So, in the present 
situation to overcome this problem it is highly needed 
to break through an alternative therapy with 
alternative approaches to the management of Diabetes 
Mellitus.  
 The alternative medicines like Ayurveda, 
Unani, Naturopathy and Yoga all are examined for its 
role in the management of Diabetes. Among them 
Ayurveda is supposed to offer a holistic approach 
towards the disease, being one of the ancient systems 
of medicine in the world. All the Ayurvedic classics 
describe Diabetes Mellitus in different forms of 
Prameha and Madhumeha. As per Vagbhata all the 
Pramehas if left untreated is eventually converted to 
Madhumeha and therefore all the Prameha is known 
by the word Madhumeha. Because all types of 
Prameha patients in its initial stages pass sweet urine 
like honey and the Rasa of that individual becomes 
sweet and that’s why is converted into Madhumeha. As 
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all the aetiologies, pathogenesis and principle of 
treatment of Madhumeha described in Ayurveda are 
comparable with Diabetes Mellitus of modern 
medicine and as Prameha is also known by the name 
Madhumeha, Prameha is likely to be the synonym of 
Diabetes Mellitus. 
 In Ayurveda, Diabetes Mellitus is classified into two 
types. [8]- 
1. Sahaja (hereditary)- The disease is associated in 
those patients genetically since birth. It can be 
compared to Juvenile Diabetes or Insulin 
Dependent Diabetes. 
2. Apathyanimittaja (acquired)- It is due to faulty 
lifestyle and the disease manifests in the later 
stage of life. It can be compared to Non-Insulin 
Dependent Diabetes. 
 Ayurvedic texts emphasized the role of two 
important factors viz. Agni and Ojas in the context of 
the disease phenomenon of Diabetes and its 
manifestation[5]. Agni and Ojas are two very unique 
concepts presented in Ayurveda entirely from a very 
new angle. Agni refers to the system of biofire present 
in the body, which is responsible for the entire 
phenomenon of tissue metabolism, assimilation and 
transformation of nutrients at molecular levels. The 
metabolic anabolies as accounted in diabetic patients 
associated with inadequacy of Insulin system could 
also be considered as errors of Agni system. Diabetes 
can be considered as an outcome of the depletion of 
certain aspects of Agni and accordingly attempts of 
restoration of the particular Dhatvagni would be 
logical approach to the treatment of Diabetes. Also 
Ayurveda propounds an equally important 
interpretation of Ojas. It is the quintessence of all the 
Dhatus of the body and is responsible for the 
biological strength and the immune defense of an 
individual. The Ayurvedic texts states that there is 
depletion of Ojas in case of Madhumeha i.e., Diabetes. 
Therefore in the management of Diabetes logically 
appropriate measures to restore Ojas in the body must 
be incorporated.[7] 
 It is in view of the facts mentioned above that 
the present investigation was undertaken where the 
drugs selected may possess some properties which 
promote the Agni and Ojas of a diabetic person 
besides simultaneous therapeutic rectification of the 
metabolic error. The selected drugs Amrita and 
Shilajatu possess Katu, Tikta, Kashaya rasa and both of 
them have Rasayana property and Ojovardhaka[5]. 
Moreover Amrita possesses Dipan, Pacan and 
immunomodulatory effect. In logical sense these drugs 
are expected to promote Agni and Ojas besides their 
direct Yukti on reduction of the Madhura rasa i.e. 
Sugar due to Tikta rasa which is opposite in nature. 
Adopting the above hypothesis the present study was 
done to evaluate the effect of the selected Ayurvedic 
formulation using appropriate clinical and laboratory 
parameters, to assess the effect of the treatment given 
on the status of the Ojas and the state of Dhatu samya 
such as correction of blood sugar levels.[7] 
Aims and objectives 
1) In the present study, assessment of drug (Amrita – 
Shilajatu yoga) response was done in terms of 
clinical symptoms of diabetes and status of Ojas. 
2) Laboratory observation in terms of fasting and 
Post prandial blood sugar at monthly interval and 
serum cholesterol before and after the treatment.  
Material and method 
Trial drug 
In the study, Amrita – Shilajatu yoga was selected as 
trial drug in the management of Prameha vis-à-vis 
Diabetes mellitus. amrita and Shilajatu are well known 
for their Rasayana and Prameghna property. 
Dosage and duration of therapeutic trial 
The Vati prepared from Amrita and Shilajatu was 
given 9 tabs daily in three divided doses for 3 (three 
months).  
Selection of patients 
 40 patients of DM were selected from the OPD of 
Dravyaguna department (Diabetic clinic) and from 
the OPD and IPD of Kayachikitsa, S.S. Hospital, 
Banaras Hindu University. 
 All were known cases of diabetic patients. 
Inclusion criteria 
 Patients having classical symptoms of Diabetes 
and uniequivocal blood sugar elevation. 
 Increased fasting blood sugar ≥110 mg/dl more 
than two occasions. 
 Increased post prandial blood sugar ≥ 140mg/dl 
Plan of the study 
 All the 40 patients were registered for the 
study after clinical and laboratory examination. Out of 
the 40 patients, 30 turned up for full follow up. All the 
diagnosed patients were divided into 3 groups nd 
following therapy was given.  
 
Group  Criteria  Therapy  
A Those NIDDM patients who were controlled by modern drug and 
were registered for the trial drug 
Amrita – Shilajatu yoga 
B The patients of NIDDM who are taking only modern medicine. Modern drug  
C Patient of uncontrolled NIDDM with modern oral hypoglycaemic 
drug treated with trial drug (mixed)  
Amrita – Shilajatu yoga 
with modern drug. 
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a) Subjective assessment 
Scale of diabetic symptoms 
 This completely depends upon the symptomatology and its grades. Improvement in symptom is directly 
proportional to the improvement in the patient’s condition and his metabolic state when there is a complete get 
rid of the symptoms, the assessment can be done quite easily. To assess the subjective feature of Diabetes 
mellitus, the clinical symptomatology was graded into four grade (0-3)scale on the basis of severity and duration. 
The change in the gradation of each symptoms was to assess the effect of given treatment. The clinical gradation 
of symptoms were as follows[4]. 
1. Polyuria  
Grade  Frequency in day Frequency at night  Volume  
0 1-4 0-2 Normal  
1 5-7 3-5 Excessive  
2 8-10 6-8 Excessive  
3 ˃ 10 ˃ 8 Excessive  
2. Polydypsia  
Grade  Frequency in day Frequency at 
night (in liters) 
0 Normal  1.5- 3  
1 Increased but frequencies of drinking water can be 
controlled  
3-4  
2 Increased with increased frequency of water intake 
(approx once in 2 hours) 
4-5 
3 Very much increased with very frequent water intake  Excessive  
3. Polyphagia  
Grade  Main meals  Light breakfast  Quantity  
0 1 1 Normal  
1 2 2-3 Increased  
2 2 3-5 Increased  
3 2 ˃5 Increased  
4. Weakness 
Grade Routine activity Weakness 
0 Normal Without feeling of weakness 
1 Normal With feeling of weakness 
2 Disturbed With feeling of weakness 
3 Bed ridden patients With feeling of weakness 
5. Cramps on walking 
Grade Cramps 
0 No cramps 
1 Cramps after walking 1 km. 
2 Cramps after walking 1/2 km. 
3 Inability to walk upto 1/2 km. 
Clinical scale for grading of Ojas 
“Tatra balena sthiraupachitamamsata sarvachestaswapratighatah swaravarnaprasado 
Bahya abhyantaranam cha karanamatmakarya pratipattibhabhati” [ Su. Su. 15/25] 
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1. Sthira mamsa/ Upachita mamsa 
a) Well formed musculature 
b) Normal musculature 
c) Average musculature 
2. Swara prasad (form of voice) 
0) Balanced smooth uninterrupted voice 
1) Takes some effort to talk 
2) Delicate and shallow voice 
3) Heena swara, feels pain in the throat while talking and feels exhausted after a few minutes to talk 
3. Varna prasad (lustre of skin) 
0) Lustre skin 
1) Normal skin without lustre 
2) Lack of lustre and dry skin 
3) Dry and lustreless skin. 
4. Twak (sense of touch) 
0) No sensory loss and abnormal sensation present 
1) Burning sensation present in the extremities 
2) Tingling and burning sensation associated with numbness 
3) Marked symptoms of peripheral neuritis. 
5. Chaksu (power of vision) 
0) Vision capacity intact 
1) Immature cataract, lustreless eyes 
2) Matured cataract with moderately reduced vision 
3) Other findings by fundoscopy, supportive of diabetic retinoscopy. 
6. Srota (sense of hearing) 
0) Normal hearing capacity 
1) Abnormal sound heard (tinnitus) 
2) Slightly reduced power of hearing 
3) Moderate to severe loss of hearing capacity. 
7. Jihwa (sense of taste) 
0) Can perceive all kinds of taste 
1) Reduced capacity to perceive taste 
2) Moderate loss of taste ability 
3) Severe loss of taste 
8. Ghrana (sense of smell) 
0) Can perceive all kinds of smell 
1) Reduced capacity to perceive smell 
2) Moderate loss of sense of smell 
3) Severe loss of sense of smell. 
9. Payu (bowel function) 
0) Intact bowel control 
1) Occasional bowel impairment 
2) Increased or decreased bowel frequency 
3) Completely altered bowel habit 
10. Upastha (Mutrendriya function) 
0) Normal or intact bladder control 
1) Occasional bladder impairment 
2) Partial retention, incontinence and increased frequency of micturation 
3) Completely altered bladder function (severe polyuria/ anuria) 
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11. Upastha jnanendriya function  
0) Normal libido 
1) Decreased frequency with normal performance 
2) Decreased frequency with inefficiency to perform sexual act 
3) No sexual stimulation at all 
12. Mana and Buddhi (Pshychological status) 
0) Psychologically well balanced 
1) Looks worried, gets angry very frequently 
2) Associated with either depression or anxiety 
3) State of psychological instability. 
13. Bala (physical strength) 
0) Can perform excessive work without getting fatigue 
1) Can carry out routine activity without getting fatigue 
2) Perform routine activity with fatigue 
3) Difficulty to perform and cannot perform routine activity. 
14. Disease propensity 
0) Rarely get minor ailments 
1) History of episode of fever, cold, diarrhoea, cough, allergy. 
2) Frequently gets due above ailments 
3) H/O major illness such as T.B, chronic fever, Recurrent infection etc 
b) Objective assessment  
Laboratory profile 
1. Blood examination  
a) Routine blood for TLC, DLC, haemoglobin percentage and erythrocyte sedimentation rate to exclude any 
infection. 
b) Blood urea and serum creatinine were done to assess the status of kidney in all patients. 
c) Liver function test 
2. Urine examination  
For specific gravity, sugar, albumin and acetone and microscopic examination for crystals, casts and cells 
was also done. 
3. Stool examination 
To rule out worm infestation and presence of occult blood if any. 
4. E.C.G  
Observation and results Of subjective parameters  
A. Incidence of clinical symptomatology in 30 cases of NIDDM   
Symptoms  No. of patients  Percentage  
Polyuria 25 83.33 
Polydypsia  9 30.00 
Polyphagia 23 76.67 
Weakness 27 90.00 
Cramps on walking 26 86.67 
Incidence of clinical symptomatology in 30 cases of NIDDM showed 83.33% had polyuria, 30.00% had polydypsia 
and 76.67 % had polyphagia. 
B. Effect of treatment  
1) On polyuria (n=30, each group 10) 
Groups 
Mean  SD 
Paired ‘t’ 
BT F1 F2 F3 BT-AT 
Group A (n=10) 1.5  0.85 1.0  0.81 0.9  0.74 0.6  0.52 0.9  0.74 t = 3.91 p < 0.01 
Group B (n=10) 1.6  0.84 1.1  0.74 0.9  0.57 1.0  0.66 0.6  0.52 t = 3.75 p < 0.01 
Group C (n=10) 2.0  0.82 1.4  0.52 1.0  0.47 0.8  0.63 1.2  0.79 t = 4.8 p < 0.001 
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The rate of shift was statistically highly significant (p<0.01) for group A, (p<0.01) for group B, (p<0.001) for 
group C. 
2) On polyphagia (n=30, each group 10) 
Groups 
Mean  SD Paired ‘t’ 
BT F1 F2 F3 BT-AT  
Group A (n=10) 1.1  0.88 0.9  0.57 0.8  0.42 0.7  0.48 0.4  0.70 t =1.82 p > 0.05 
Group B (n=10) 0.9  0.74 0.7  0.48 0.6  0.69 0.7  0.67 0.2  0.42 t = 1.53 p > 0.05 
Group C (n=10) 1.3  0.95 1.0  0.67 0.9  0.57 1.0  0.66 0.3  0.48 t = 2.0 p > 0.05 
The rate of shift was statistically insignificant (p˃0.05) for group A, (p˃0.05) for group B, (p˃0.05) for group C. 
3) On polydypsia (n=30, each group 10) 
Groups 
Mean  SD 
Paired ‘t’ 
BT F1 F2 F3 BT-AT 
Group A (n=10) 1.2  0.79 0.7  0.48 0.6  0.52 0.5  0.53 0.7  0.67 t = 3.3 p < 0.01 
Group B (n=10) 1.3  0.95 0.9  0.57 0.6  0.52 0.7  0.48 0.6  0.70 t = 2.73 p < 0.05 
Group C (n=10) 1.9  0.74 1.2  0.63 0.7  0.67 0.6  0.70 1.2  0.79 t=4.8 p<0.001 
The rate of shift was statistically highly significant (p<0.01) for group A, significant at (p<0.05) for group B, highly 
significant at (p<0.001) for group C.  
4) Effect of Treatment on Weakness (n = 30) 
Groups 
Mean  SD 
Paired ‘t’ 
BT F1 F2 F3 BT-AT 
Group A (n=10) 1.3  0.95 0.9  0.57 0.6  0.52 0.3  0.48 1.0  0.82 t = 3.85 p < 0.01 
Group B (n=10) 1.6  0.70 1.2  0.63 1.1  0.74 1.0  0.67 0.6  0.70 t = 2.73 p < 0.05 
Group C (n=10) 1.8  0.79 1.1  0.57 0.8  0.42 0.6  0.52 1.2  0.79 t = 4.8 p < 0.001 
It was statistically highly significant (p<0.001). 
5) Effect of Treatment on Cramps on walking (n = 30) 
Groups 
Mean  SD 
Paired ‘t’ 
BT F1 F2 F3 BT-AT 
Group A (n=10) 1.2  0.79 1.0  0.67 0.8  0.42 0.7  0.48 0.5  0.53 t = 2.99 p < 0.02 
Group B (n=10) 1.3  0.95 1.0  0.67 0.8  0.79 0.9  0.74 0.4  0.52 t = 2.5 p < 0.05 
Group C (n=10) 1.4  0.97 1.1  0.74 0.9  0.57 0.7  0.67 0.7  0.67 t = 3.33 p < 0.001 
For group A, statistically significant (p<0.02). It was statistically significant (p<0.05), for group B. In the Group C it 
was statistically highly significant. 
6) On the treatment of Ojas (n=30, each group 10) 
Groups 
Mean  SD 
Paired ‘t’ 
BT AT BT – AT 
Group A (n=10) 10.6  4.27 7.8  1.99 2.8  2.62 t = 3.37, p < 0.01 
Group B (n=10) 9.9  2.42 8.9  1.27 1.0  1.56 t = 2.04, p > 0.05 
Group C (n=10) 11.6  4.70 7.5  2.31 4.1  2.64 t = 4.88, p < 0.001 
The rate of shift was statistically highly significant (p<0.01) for group A, insignificant at (p˃0.05) for group 
B,highly significant at (p<0.001) for group C. 
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Objective parameters 
7) On the treatment on blood sugar fasting (n=30, each group 10) 
Groups 
Mean  SD 
Paired ‘t’ 
BT F1 F2 F3 BT-AT 
Group A (n=10) 124.4  2.17 122.90  0.99 122.40  0.84 122.10  0.99 2.30  2.41 t=3.03 p<0.02 
Group B (n=10) 137.10  4.89 120.00  7.35 118.10  8.80 115.60  10.55 19.90  15.98 t=3.93 p<0.01 
Group C (n=10) 160.70  15.87 118.70  12.10 117.10  14.57 114.7  16.30 46.00  29.20 t=4.97 p<0.001 
The rate of shift was statistically significant (p<0.02) for group A, highly significant at (p<0.01) for group B, highly 
significant at (p<0.001) for group C. 
8) On the treatment on blood sugar Post prandial (n=30, each group 10) 
Groups 
Mean  SD 
Paired ‘t’ 
BT F1 F2 F3 BT-AT 
Group A (n=10) 204.10  2.99 200.70  4.50 200.00  4.57 197.8  7.33 6.80  7.04 t = 3.05 p < 0.02 
Group B (n=10) 242.60  19.31 198.40  16.31 195.90  17.59 194.10  19.37 48.50  34.91 t = 4.38 p < 0.01 
Group C (n=10) 261.10  29.40 195.60  16.06 193.50 17.98 191.70  20.66 69.40  43.93 t = 4.99 p <0.001 
The rate of shift was statistically significant (p<0.02) for group A, highly significant at (p<0.01) for group B, highly 
significant at (p<0.001) for group C. 
DISCUSSION 
 The present study not only corrects the 
metabolic error by maintaining the Agni in 
equilibrium but also overcomes its various 
complications by stabilizing the status of Ojas in 
NIDDM patients. The ancient declaration of the 
scientist that it is because of Ojakshaya, which is the 
essence of all the Dhatus i.e., the natural immunity of 
the body. Acharya Sushruta has clearly depicted that if 
Ojakshaya takes place organic decay takes place. This 
observation of Sushruta gives guideline to proceed 
towards Rasayana therapy in case of Diabetes 
mellitus. Another level of glucose remains in Ojas. This 
quantum of glucose in Ojas if hampered then blood 
sugar rises i.e., DM originates. The Oja is expelled out 
of body through urinary passages by vitiated Vayu. 
This vitiation of Vayu is due to Dhatukshaya and 
Ojokshaya both. Therefore in this condition Rasayana 
therapy is the only answer for proper rescue of the 
disease and hence Rasayana drug like Amrita Shilajatu 
yoga was chosen. Thus apart from concept of Agni and 
Ojha in relation to Ojha, the hypoglycaemic effect of an 
indigenous compound drug Amrita –Shilajatu yoga 
and the Rasayana effect of drug on Prameha patient is 
also evaluated by assessing the status of Ojas. 
 Statistical evaluation was done in clinical and 
laboratory parameters and are represented in the 
tables above after calculating mean, SD, ‘t’ and ‘p’ 
value. 
 In case of group A mean reduction of all the 
clinical parameters are more than that group B. 
Although group A patients were treated with oral 
hypoglycaemic drug and their blood sugar brought to 
border line before registration but other symptoms 
were almost as usual and it was reduced significantly 
after have given the trial drug which is more than 
mean reduction of group B. 
 Statistically significant to highly significant 
was observed in both group A and B in clinical 
symptoms like polyuria, polydysia, weakness, cramps 
on leg and insignificant in polyphagia. The most 
important aspect of the present study has been the 
evaluation of the status of Ojas in patients of NIDDM 
before and after the trial treatment based on clinical 
grade score developed on the basis of classical 
reference. The 14 point scale of Ojas indicates the 
state and integrity of all vital organs of the body. The 
high initial mean of these symptoms is suggestive of 
derangement in the status of Ojas before treatment. 
The clinically and statistically improvement indicates 
a state of homeostasis in the state of Ojas after trial 
therapy. 
 In group A improvement in terms of mean 
difference of 2.8± 2.62 was observed in the status of 
Ojas which is statistically highly significant. In group C 
more improvement in terms of mean difference of 
4.1±2.64 was observed in the status of Ojas which is 
statistically highly significant. In case of group B 
difference in the status of Ojas is 1.0±1.56 which is 
statistically insignificant. In group A patients before 
treatment with trial drug their blood sugar level was 
brought to normal level with the treatment of modern 
drug and it was stopped. And after that with the 
treatment of trial drug slight mean reduction occurs 
within the normal limit also. 
 Regarding the blood sugar fasting initial mean 
and SD for group A was 120±2.17 which after 3 
months of treatment came down to 122.10±0.99. The 
initial mean reduction was 2.30±2.41. the ‘t’ value was 
statistically significant. For group B, initial mean and 
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SD was 137.10±4.89, after 3 months of treatment 
reduced to 115.60±10.55. The t value was statistically 
significant (t=3.93). For group C, initial mean and SD 
was 160.70±15.87, after 3 months of treatment 
reduced to114.7 ±16.30. The t value was statistically 
highly significant (t=4.97). the total mean reduction 
was 46.00±29.20 and the ‘t’ was statistically highly 
significant (t=4.97, p<0.001) which is more than group 
A and group B that suggests the synergistic effect of 
both modern and trial drug.  
 Regarding the blood sugar post prandial initial 
mean and SD for group A was 204±2.99 which after 3 
months of treatment came down to 197.8±7.33. The 
initial mean reduction was 6.80±7.04. The ‘t’ value 
was statistically significant, t= 3.05. For group B, initial 
mean and SD was 242.60±19.31, after 3 months of 
treatment reduced to 194.10±19.37. The total mean 
reduction was 48.50±34.91. the ‘t’ value was 
statistically highly significant. While in group C 
improvement was statistically highly significant.  
 In the overall observations it has been seen 
that more significance is seen in Group A patient than 
group B and in case of Ojas group A is statistically 
significant but the group B is insignificant. Regarding 
blood sugar in Group A although trial drug was given 
after controlling the blood sugar but it maintains in 
normal range rather than slight reduction in total 
mean was seen and it was statistically significant.  
 Thus the findings obtained suggest Amrita – 
Shilajatu yoga to be mild to moderate remedy in the 
treatment of Prameha vis-à-vis NIDDM by improving 
Ojas and Agni. The trial therapy is more effective in 
group C patients where the trial drug was continued 
with the ongoing modern treatment. 
CONCLUSION 
 Amrita – Shilajatu yoga has been selected as a 
trial drug keeping in view of its potential influence to 
Agni and Ojas and by thus restoring Dhatu samya. The 
trial drug probably acts in NIDDM by improving the 
status of Agni in general and Medoagnidhatvagni in 
particular and thereby resulting in qualitative change 
in the status of the Medodhatu or fat content of body, 
thus re-vitalising Insulin receptors and preventing 
further insulin antagonism. these two drugs have 
Katu, Tikta, Kashaya and both the drugs possess 
Rasayana, Ojovardhaka agniprada effects. Besides 
these Amrita is having Deepana pacan and 
immunomodulator properties. The above devised 
treatment seems to have produced metabolic 
correction in the patients of diabetes promoting the 
state of Agni and Ojas with overall improvement in the 
total health. 
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